Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Gainers Evelo Biosciences, Inc. (NASDAQ:EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #...
Stay updated with breaking news from Humanigen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gainers Evelo Biosciences, Inc. (NASDAQ:EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #...
Humanigen, Inc. (NASDAQ:HGEN – Get Rating) shares rose 11.9% during mid-day trading on Tuesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 2,224,434 shares were traded during trading, a decline of 5% from the average daily volume of 2,341,994 shares. The stock had previously closed at $0.15. Analysts Set […]
Humanigen, Inc.today extended previously reported results by presenting additional, statistically significant hematologic improvements and reductions in inflammatory markers from lenzilumab, its investigational drug, in a Phase 2/3 trial of treatment-naïve participants with chronic myelomonocytic leukemia and RAS-pathway mutations.
CELLECTIS A corporation with a share capital of 2,779,188.40 euros Headquarters: 8, rue de la Croix Jarry - 75013 Paris ... | June 1, 2023
Credit Suisse Group restated their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a report issued on Monday morning, Benzinga reports. The firm currently has a $0.50 price objective on the stock. Separately, Cantor Fitzgerald initiated coverage on Humanigen in a research report on Wednesday, January 11th. They set a neutral rating […]